BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21786315)

  • 1. Advantages of isovolemic hemodilution-red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patients.
    Sarode R; Matevosyan K; Rogers ZR; Burner JD; Rutherford C
    J Clin Apher; 2011; 26(4):200-7. PubMed ID: 21786315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isovolemic hemodilution-red cell exchange for prevention of cerebrovascular accident in sickle cell anemia: the standard operating procedure.
    Matevosyan K; Anderson C; Sarode R
    J Clin Apher; 2012; 27(2):88-92. PubMed ID: 22302664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the depletion-red cell exchange program with the Spectra Optia and the isovolemic hemodilution-red cell exchange method with the COBE Spectra in sickle cell disease patients.
    Poullin P; Sanderson F; Bernit E; Brun M; Berdah Y; Badens C
    J Clin Apher; 2016 Oct; 31(5):429-33. PubMed ID: 26274351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rinseback during red blood cell exchange with COBE Spectra does not affect fraction of cells remaining or post-exchange hematocrit.
    Bhagat R; Matevosyan K; Jones R; Vetus ML; Burner J; Sarode R
    J Clin Apher; 2010; 25(6):347-9. PubMed ID: 20623784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
    Godfrey GJ; Lockwood W; Kong M; Bertolone S; Raj A
    Pediatr Blood Cancer; 2010 Dec; 55(6):1134-7. PubMed ID: 20979172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of a new apheresis device for automated red blood cell exchange procedures in patients with sickle cell disease.
    Quirolo K; Bertolone S; Hassell K; Howard T; King KE; Rhodes DK; Bill J
    Transfusion; 2015 Apr; 55(4):775-81. PubMed ID: 25330984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
    Ziemba Y; Xu C; Fomani KM; Nandi V; Yuan T; Rehmani S; Sachais BS; Appiah-Kubi AO; Aygun B; Louie JE; Shi PA
    Transfusion; 2021 Feb; 61(2):526-536. PubMed ID: 33368343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A; Ware RE; Thornburg CD
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic red blood cell exchange to prevent clinical complications in sickle cell disease.
    Cabibbo S; Fidone C; Garozzo G; Antolino A; Manenti GO; Bennardello F; Licitra V; Calabrese S; Costantino F; Travali S; Distefano R; Bonomo P
    Transfus Apher Sci; 2005 Jun; 32(3):315-21. PubMed ID: 15908276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.
    Ware RE; Zimmerman SA; Sylvestre PB; Mortier NA; Davis JS; Treem WR; Schultz WH
    J Pediatr; 2004 Sep; 145(3):346-52. PubMed ID: 15343189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the benefits of isovolemic hemodilution red cell exchange for sickle cell disease.
    Reddy MS; Alkashash A; Nord A; Tetrick A
    J Clin Apher; 2023 Oct; 38(5):522-528. PubMed ID: 37092306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia.
    Hulbert ML; Scothorn DJ; Panepinto JA; Scott JP; Buchanan GR; Sarnaik S; Fallon R; Chu JY; Wang W; Casella JF; Resar L; Berman B; Adamkiewicz T; Hsu LL; Smith-Whitley K; Mahoney D; Woods G; Watanabe M; DeBaun MR
    J Pediatr; 2006 Nov; 149(5):710-2. PubMed ID: 17095350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Spectra Optia and COBE Spectra apheresis systems' performances for red blood cell exchange procedures.
    Kim J; Joseph R; Matevosyan K; Sarode R
    Transfus Apher Sci; 2016 Dec; 55(3):368-370. PubMed ID: 27789125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
    Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
    Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term blood transfusion in sickle-cell anemia].
    De Montalembert M; Girot R; Boiteux F; Manigne P
    Arch Fr Pediatr; 1987 May; 44(5):349-54. PubMed ID: 3619565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.
    Mazumdar M; Heeney MM; Sox CM; Lieu TA
    Pediatrics; 2007 Oct; 120(4):e1107-16. PubMed ID: 17768181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advantages and difficulties of an erythrocytapheresis program for sickle-cell patients: a pediatric experience].
    Filhon B; Dumesnil C; Holtermann C; Bastit D; Schneider P; Vannier JP
    Arch Pediatr; 2012 Jun; 19(6):572-8. PubMed ID: 22542721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy.
    Asma S; Kozanoglu I; Tarım E; Sarıturk C; Gereklioglu C; Akdeniz A; Kasar M; Turgut NH; Yeral M; Kandemir F; Boga C; Ozdogu H
    Transfusion; 2015 Jan; 55(1):36-44. PubMed ID: 25070465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.